E-Poster Presentation 33rd Lorne Cancer Conference 2021

Small Bowel Adenocarcinoma: Revisited (#192)

Muhammad Farqhan Rosley 1 , Richard Maguire 1 , Mahanama Dissanayake 1
  1. Mackay Base Hospital, Mackay, QUEENSLAND, Australia
Publish consent withheld
  1. 1. Overman MJ. Rare but real: management of small bowel adenocarcinoma. Am Soc Clin Oncol Educ Book. 2013:189-93. doi: 10.14694/EdBook_AM.2013.33.189. PMID: 23714497.
  2. 2. Hutchins RR, Bani Hani A, Kojodjojo P, Ho R, Snooks SJ. Adenocarcinoma of the small bowel. ANZ J Surg. 2001 Jul;71(7):428-37. doi: 10.1046/j.1440-1622.2001.02149.x. PMID: 11450920.
  3. 3. Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011;3(3):33-42. doi:10.4251/wjgo.v3.i3.33
  4. 4. Cancer Registration Statistics, England Statistical Bulletins.; Available online: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  5. 5. Shenoy S. Genetic risks and familial associations of small bowel carcinoma. World J. Gastrointest. Oncol. 2016;8:509–519. doi: 10.4251/wjgo.v8.i6.509. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  6. 6. Jagelman D.G., DeCosse J.J., Bussey H.J. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet. 1988;1:1149–1151. doi: 10.1016/S0140-6736(88)91962-9. [PubMed] [CrossRef] [Google Scholar]
  7. 7. Vasen H.F., Bulow S., Myrhoj T., Mathus-Vliegen L., Griffioen G., Buskens E., Taal B.G., Nagengast F., Slors J.F., de Ruiter P. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut. 1997;40:716–719. doi: 10.1136/gut.40.6.716. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  8. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer. 2001;91:854–862. doi: 10.1002/1097-0142(20010215)91:43.0.CO;2-Z. [PubMed] [CrossRef] [Google Scholar]
  9. Palascak-Juif V., Bouvier A.M., Cosnes J., Flourié B., Bouché O., Cadiot G., Lémann M., Bonaz B., Denet C., Marteau P., et al. Small Bowel Adenocarcinoma in Patients with Crohn’s Disease Compared with Small Bowel Adenocarcinoma De Novo. Inflamm. Bowel Dis. 2005;11:828–832. doi: 10.1097/01.mib.0000179211.03650.b6. [PubMed] [CrossRef] [Google Scholar]
  10. Shaukat A., Virnig D.J., Howard D., Sitaraman S.V., Liff J.M., Lederle F.A. Crohn’s disease and small bowel adenocarcinoma: A population-based case-control study. Cancer Epidemiol. Biomark. Prev. 2011;20:1120–1123. doi: 10.1158/1055-9965.EPI-10-1281. [PubMed] [CrossRef] [Google Scholar]
  11. Askling J., Linet M., Gridley G., Halstensen T.S., Ekstrom K., Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435. doi: 10.1053/gast.2002.36585. [PubMed] [CrossRef] [Google Scholar]
  12. Lowenfels A.B., Sonni A. Distribution of small bowel tumors. Cancer Lett. 1977;3:83–86. doi: 10.1016/S0304-3835(77)94394-4. [PubMed] [CrossRef] [Google Scholar]
  13. Maglinte DD, O'Connor K, Bessette J, Chernish SM, Kelvin FM. The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol. 1991 Mar;86(3):304-8. PMID: 1998312.
  14. Zaanan A, Costes L, Gauthier M, et al. Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Ann Oncol. 2010;21(9):1786-1793. doi:10.1093/annonc/mdq038